Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014

Drug and Alcohol Dependence

Volumn 158, Issue , 2016, Pages 154-158

  Rácz, József ^a,b,c   Csák, Róbert ^b,c   Tóth, Krisztina Tímea ^a   Tóth, Eszter ^a   Rozmán, Klaudia ^a   Gyarmathy, V Anna ^b,d  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Blue Point Outpatient and Prevention Centre   (Hungary)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hungary; Needle exchange program; New psychoactive substances; People who inject drugs; Time series

Indexed keywords

4' METHYLMETHCATHINONE; AMPHETAMINE DERIVATIVE; DIAMORPHINE; NEW PSYCHOACTIVE SUBSTANCE; PENTEDRONE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; AMPHETAMINE;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; DRUG USE PATTERN; FEMALE; HEALTH BEHAVIOR; HIGH RISK BEHAVIOR; HUMAN; HUNGARY; INJECTING RISK; MAJOR CLINICAL STUDY; MALE; MISCELLANEOUS NAMED GROUPS; NEEDLE EXCHANGE; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; RISK; SEX DIFFERENCE; TIME SERIES ANALYSIS; YOUNG ADULT; ADOLESCENT; PREVALENCE; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; TRENDS;

ADOLESCENT; ADULT; AMPHETAMINE; FEMALE; HEROIN; HUMANS; HUNGARY; MALE; NEEDLE-EXCHANGE PROGRAMS; PREVALENCE; PSYCHOTROPIC DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84951735545     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.10.034     Document Type: Article

References (22)

1. Coppola M., Mondola R. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol. Lett. 2012, 208:12-15.
2. European Drug Report 2015: Trends and Developments 2015, European Monitoring Centre for Drugs and Drug Addiction, Office for Official Publications of the European Communities, Luxembourg.
3. European Monitoring Centre for Drugs and Drug Addiction, 2015b. New psychoactive substances in Europe. An update from the EU Early Warning System. Luxembourg.
4. Földes,A., 2015. Siker! A drog oldotta meg a vidéki alkoholproblémát [Success! Drugs have solved the alcohol problem in rural areas]. Available at 〈http://index.hu/belfold/2015/04/16/dizajnerdrogdalun/〉.
5. Gyarmathy V.A., Neaigus A., Li N., Ujhelyi E., Caplinskiene I., Caplinskas S., Latkin C.A. Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high-a comparison of Hungary and Lithuania. Eur. Addict. Res. 2010, 16:220-228.
6. Gyarmathy V.A., Sárosi P. Hepatitis C prevalence among people who inject drugs in Hungary. Lancet Infect. Dis. 2015, 15(11):1261-1262.
7. György E. A "Nyócker"-egy városnegyed, mint reprezentációs eszköz. Regio 2009, 20:119-134.
8. 2011 National Report to the EMCDDA. "Hungary". New Developments, Trends and in-Depth Information on Selected Issues 2011, Hungarian National Focal Point, National Focal Point Hungary, Budapest.
9. A Nemzeti Drog Fókuszpont Által Összegyujtött Tucsere információk 2014 2015, Hungarian National Focal Point, National Focal Point Hungary, Budapest.
10. Karila L., Megarbane B., Cottencin O., Lejoyeux M. Synthetic cathinones: a new public health problem. Curr. Neuropharmacol. 2015, 13:12-20.
11. King L.A., Sedefov R. Early-Warning System on New Psychoactive Substances. Operating Guidelines 2007, European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.
12. Péterfi A., Tarján A., Horváth G.C., Csesztregi T., Nyírády A. Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones. Drug Test. Anal. 2014, 6:825-831.
13. Rácz J., Csák R. Emergence of novel psychoactive substances among clients of a needle exchange programme in Budapest. Orv. Hetil. 2014, 155:1383-1394.
14. Rácz J., Gyarmathy V.A., Csák R. New cases of HIV among PWIDs in Hungary: false alarm or early warning?. Int. J. Drug Policy 2015, pii:S0955-3959(15)00179-6. [Epub ahead of print]. 10.1016/j.drugpo.2015.05.026.
15. Schifano F., Albanese A., Fergus S., Stair J.L., Deluca P., Corazza O., Davey Z., Corkery J., Siemann H., Scherbaum N. Mephedrone (4-methylmethcathinone; "meow meow"): chemical, pharmacological and clinical issues. Psychopharmacology 2011, 214:593-602.
16. Seely K.A., Patton A.L., Moran C.L., Womack M.L., Prather P.L., Fantegrossi W.E., Radominska-Pandya A., Endres G.W., Channell K.B., Smith N.H. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Sci. Int. 2013, 233:416-422.
17. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clin. Toxicol. 2011, 49:499-505.
18. Szily E., Bitter I. Designer drugs in psychiatric practice-a review of the literature and the recent situation in Hungary. Neuropsychopharmacol. Hung. 2013, 15:223-231.
19. Tarján A., Dudás M., Gyarmathy V.A., Rusvai E., Tresó B., Csohán Á. Emerging risks due to new injecting patterns in Hungary during austerity times. Subst. Use Misuse 2015, 50:1-11.
20. Topp L., Day C., Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend. 2003, 70:275-286.
21. New Psychoactive Substances 2013, United Nations Office on Drugs and Crime, United Nations, New York.
22. The Challenge of New Psychoactive Substances 2013, United Nations Office on Drugs and Crime, United Nations, New York.